Prostate cancer: focused ultrasound redefines the balance between oncologic control and functional preservation

By Elodie Vaz | Published on March 9, 2026 | 3 min read


With nearly 60,000 new cases each year in France, prostate cancer is the most common cancer in men and the third leading cause of cancer-related mortality. One in six men over the age of 60 is affected. Although the prognosis of localized disease is often favorable, treatment remains associated, from the patient’s perspective, with feared functional sequelae. Up to 90% of patients report concerns about complications such as urinary incontinence and erectile dysfunction after treatment.